Span Diagnostics transfers In-vitro Diagnostics business to Arkray Healthcare

09 Mar 2015 Evaluate

Span Diagnostics has transferred its business undertaking to Arkray Healthcare with effect from March 05, 2015. The company had earlier on January 24, 2014 entered into Business Purchase Agreement (BPA) with Arkray Healthcare for transfer of its In-vitro Diagnostics business to Arkra Healthcare.

Further, Span Biotronics has ceased to be a subsidiary of Span Diagnostics pursuant to the transfer of shares from Span Diagnostics to Arkray Healthcare with effect from March 05, 2015.

Span Diagnostics caters to several different sections of diagnostics like Immunology, Biochemistry, Microbiology, Serology, Histopathology and instrumentation. The company’s manufacturing capabilities comprise of advanced infrastructure, highly trained and motivated pool of scientific and technical personnel and years of experience.

Span Divergent Share Price

31.92 0.00 (0.00%)
01-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×